Benzinga's Top Downgrades

Analysts at Canaccord Genuity downgraded Coach

from “buy” to “hold.” The target price for Coach has been lowered from $65 to $62. Coach's shares closed at $54.59 on Friday. Analysts at Deutsche Bank downgraded Expedia

from “buy” to “hold.” The target price for Expedia has been lowered from $66 to $51. Expedia's shares closed at $51.73 on Friday. Goldman Sachs downgraded NuVasive

from “neutral” to “sell.” The target price for NuVasive has been lowered from $25 to $22. NuVasive's shares closed at $26.27 on Friday. Analysts at Bernstein downgraded Merck & Company

from “outperform” to “market perform.” The target price for Merck & Company has been lowered from $53 to $50. Merck's shares closed at $47.29 on Friday.